Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Community Healthcare Trust, Inc. (CHCT)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
$14.74+1.59%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.49 → 0.49 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CHCT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Increase cash from operating activities to at least $13.74 million in Q1 2026 | Cash from operations rose to $13.74 million in Q1 2026. | Intact | cash from operations falls below $13.74 million in 2026-Q1 | Cash from operations: $17.533M FY2026-Q2; GAAP. Published target: >=13.74 million USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 4, 202617,533,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a healthcare real estate business with a multi-year thesis built around portfolio improvement and reinvestment. The thesis is intact and the latest signal is mildly favorable, though recent financial performance is neutral and near-term results remain uncertain.
The evidence describes CHCT as cheap versus peers, with a low-confidence valuation model and a negative expectations gap. Pricing is tagged as justified, and no fragility warning was triggered, but the evidence does not show precisely what operating assumptions the market expects.
Near term, results may remain uneven: CHCT has recorded both earnings beats and a miss, and the evidence flags a meaningful risk of missing the next print. Over the next 1 to 3 years, management is retaining capital after a 31% dividend reduction, aiming to improve occupancy to 92% and reinvest at stated yields of 9% to 12%; progress on those aims is still mixed.
The multi-year thesis depends on occupancy improving and reinvestment producing the intended returns. Near term, a guidance cut would be a meaningful negative, while lower interest rates could support real estate; weakness among sector peers could remove that support.
The long-term thesis remains intact, with improving quality signals but mixed execution and a notable risk around the next results. The dividend reduction and progress on occupancy and reinvestment are central to the 1 to 3 year view. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Increase dividend per share to at least $0.48 in Q1 2026 |
| It is increasing dividends steadily to about $0.48 per share in early 2026. |
| Broken |
| dividend per share fails to reach $0.48 by 2026-Q1 |
Dividend per share: $0.33 per share FY2026-Q3; GAAP. Published target: >=0.48 USD per share. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 3, 20260.33 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain positive net income of at least $2.55 million in Q1 2026 | The company maintains positive net income despite some recent declines. | Intact | net income falls below $2.55 million in 2026-Q1 | Net income: $3.068M FY2026-Q3; GAAP. Published target: >=2.55 million USD. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 3, 20263,068,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Unavailable → $0.49 · observed estimates
$0.14B → $0.13B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | Unavailable | $136,105,250 | — / 4 |
| 2026-07-25 | Unavailable | $136,105,250 | — / 4 |
| 2026-07-26 | Unavailable | $136,105,250 | — / 4 |
| 2026-07-27 | $0.59 | $133,371,800 | 1 / 3 |
| 2026-07-28 | Unavailable | $136,105,250 | — / 4 |
| 2026-07-29 | Unavailable | $136,105,250 | — / 4 |
| 2026-07-30 | Unavailable | $136,105,250 | — / 4 |
| 2026-07-31 | Unavailable | $136,105,250 | — / 4 |
| 2026-08-01 | Unavailable | $136,105,250 | — / 4 |
| 2026-08-02 | Unavailable | $136,105,250 | — / 4 |
| 2026-08-03 | $0.59 | $133,371,800 | 1 / 3 |
| 2026-08-04 | $0.59 | $133,371,800 | 1 / 3 |
| 2026-08-05 | $0.59 | $133,371,800 | 1 / 3 |
| 2026-08-06 | $0.59 | $133,371,800 | 1 / 3 |
| 2026-08-07 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-08 | Unavailable | $135,033,000 | — / 4 |
| 2026-08-09 | Unavailable | $135,033,000 | — / 4 |
| 2026-08-10 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-11 | Unavailable | $135,033,000 | — / 4 |
| 2026-08-12 | Unavailable | $135,033,000 | — / 4 |
| 2026-08-13 | Unavailable | $135,033,000 | — / 4 |
| 2026-08-14 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-15 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-16 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-17 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-18 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-19 | $0.59 | $133,011,800 | 1 / 3 |
| 2026-08-20 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-21 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-22 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-23 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-24 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-25 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-26 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-27 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-28 | $0.49 | $131,770,600 | 1 / 3 |
| 2026-08-29 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-08-30 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-08-31 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-01 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-02 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-03 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-04 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-05 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-06 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-07 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-08 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-09 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-10 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-11 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-12 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-13 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-14 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-15 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-16 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-17 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-18 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-19 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-20 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-21 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-22 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-23 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-24 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-25 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-26 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-27 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-28 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-29 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-09-30 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-01 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-02 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-03 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-04 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-05 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-06 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-07 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-08 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-09 | $0.49 | $130,555,600 | 1 / 3 |
| 2026-10-10 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-11 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-12 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-13 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-14 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-15 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-16 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-17 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-18 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-19 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-20 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-21 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-22 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-23 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-24 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-25 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-26 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-27 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-28 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-29 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-30 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-10-31 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-11-01 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-11-02 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-11-03 | $0.49 | $130,108,200 | 1 / 3 |
| 2026-11-04 | $0.49 | $130,112,599 | 1 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.